Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone. - Wikidata - wikimedia - TriplyDB

Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.

Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.

http://www.wikidata.org/entity/Q37131738

about

Members of the DAN family are BMP antagonists that form highly stable noncovalent dimers A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.Recent advances in bone-targeted therapies of metastatic prostate cancer Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancer.Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destruction Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer.Molecular signaling pathways mediating osteoclastogenesis induced by prostate cancer cells.Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling.Homing of cancer cells to the bone Denosumab: Delay of bone metastasis in men with nonmetastatic castrate-resistant prostate cancer.The expression patterns of gremlin 1 and noggin in normal adult and tumor tissues Novel esophageal squamous cell carcinoma bone metastatic clone isolated by scintigraphy, X ray and micro PET/CT.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Steps in prostate cancer progression that lead to bone metastasis Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancer.Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiation in vitro.RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation.Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.The Dual Role of Bone Morphogenetic Proteins in Cancer.RANKL inhibition: Clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases

P2860

Q24300782-C32D879D-1207-46CE-AEF6-7960E7F64C1A Q30504566-56581152-7AE0-4B26-AFBC-FDDBCDABBA7A Q33703763-F95221A3-862C-4B03-B50B-603E3757021B Q33819310-166BBC96-4837-4832-A2C4-EFB4A26925FB Q34284100-6D16A8FB-10D6-4718-83EA-F0521563D906 Q34574593-5ACC264A-B5BB-4F0B-B618-824A1B81AF5E Q34629549-4D6AEB92-B31A-4A45-A7E9-4492125BCDC6 Q35076418-13304D0E-A099-4539-B762-CC5FC7F7C129 Q35106750-2BC9FFE2-A45C-4BE6-AF72-ADB99BCAFAB6 Q35603135-E796DEEA-378D-4E76-8D9C-B5580122A736 Q36450727-DFDFAA2A-0694-49BF-8055-37CEE9385041 Q36956229-4AC9C149-D2A4-4226-BC0E-1251F16740F2 Q37578682-71F20D4E-CFB2-4590-B746-861937295B05 Q37615017-A2A522D2-AD95-4D25-98B7-307902B3EEB9 Q37848782-C45ACB89-68FD-4613-BCF6-DCFD17783CB9 Q38819069-E16A8159-A0C2-42A2-B65F-00BE54168756 Q39538019-00BB3D08-9B32-4BE6-B4E3-7679DB5ED861 Q39590554-FD36BB84-742E-401B-B94A-BE1835525813 Q41859712-E8F930D9-AA54-4975-BB17-09AF4EC38782 Q47163689-E1D9912B-830B-4A9E-A6A8-74A2FFDB117D Q57904702-AEF36D32-81B1-4B21-9126-ACB9D944D7AF

P2860

Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.

http://www.wikidata.org/entity/Q37131738

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Influence of simultaneous targ ...... rostate cancer lesion in bone.

@en

Influence of simultaneous targ ...... rostate cancer lesion in bone.

@nl

type

label

Influence of simultaneous targ ...... rostate cancer lesion in bone.

@en

Influence of simultaneous targ ...... rostate cancer lesion in bone.

@nl

prefLabel

Influence of simultaneous targ ...... rostate cancer lesion in bone.

@en

Influence of simultaneous targ ...... rostate cancer lesion in bone.

@nl

P1433

Q37131738-DD1985C5-B3B7-4E15-810F-0C7FC4B76D07

P1476

Q37131738-54F73A7E-8B5C-491C-B680-BE2022A850B1

P2093

Q37131738-574C1FC7-8E05-43CF-A5AA-16D5481163C8

Q37131738-624F7656-D569-4FF4-A746-73620EDC5CB9

Q37131738-7BBEF31E-F438-4703-A657-6B4BD1575894

Q37131738-85A43AFA-6A22-49F7-B3AF-3C7C488CAD88

Q37131738-A9F1960B-EB04-4E22-9175-D69411CF2B1E

Q37131738-AFCA33C4-48D0-4BCC-869E-8F7BFD890E46

Q37131738-C175863C-1A21-42BD-9636-C2E0C637D779

P2860

Q37131738-01753FAB-9E5D-4AC0-B526-44DA39F7D10F

Q37131738-03468379-ECEE-4983-976B-D00D96F9D2A2

Q37131738-16B649CA-9D46-4B97-B74D-EB26FD39612B

Q37131738-1959E2B9-59DF-4862-BC7B-13A443CBBD45

Q37131738-2624F154-ADEE-465F-84ED-6B76AE8E5599

Q37131738-2770BD6B-57F3-41B6-84AE-599FAB625C41

Q37131738-3737D276-B97A-4872-AF67-82E3CF00DD46

Q37131738-38846EDC-D9AF-44B2-BDD4-4132CCF506FA

Q37131738-397D452C-FB60-4CE7-A7DF-C457C0BDD026

Q37131738-3A037941-BB95-42E0-BB3D-D88347D7BD9F

P304

Q37131738-CCDF408E-295A-43A4-A902-D9867350EF02

P31

Q37131738-4F97F822-59EE-4708-854B-CE42E4552572

P356

Q37131738-30CC5171-0E25-4C13-A293-5BCA22833C27

P433

Q37131738-634079C5-B7FA-4810-822E-7C9AF5F0CB4F

P478

Q37131738-2AB007BC-0FE5-4EED-BF29-6A42A4792365

P50

Q37131738-1A8CBD0E-55F3-41A0-BD8B-65ADE11E4640

P577

Q37131738-88E4B036-BD78-432F-9BD4-4101BD10735D

P5875

Q37131738-C1FD88A2-3731-47AE-BC66-BEB1D570953B

P698

Q37131738-6AC2D742-8C43-424F-9D9F-84C7A76BD4B9

P921

Q37131738-4BD306D3-DABB-4793-BB55-BBF3546134BF

P932

Q37131738-1FA3F0F6-625F-4C86-8FA4-A26327F100AB

P356

J.BONE.2008.09.009

P1433

P1476

Influence of simultaneous targ ...... rostate cancer lesion in bone.

@en

P2093

Arion F Chatziioannou

http://www.w3.org/2001/XMLSchema#string

Christine O Kang

http://www.w3.org/2001/XMLSchema#string

David Stout

http://www.w3.org/2001/XMLSchema#string

Frank A Petrigliano

http://www.w3.org/2001/XMLSchema#string

Jay R Lieberman

http://www.w3.org/2001/XMLSchema#string

Nancy Q Liu

http://www.w3.org/2001/XMLSchema#string

William C Dougall

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor metastasis to bone

The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Structural basis of BMP signalling inhibition by the cystine knot protein Noggin

Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer

Bone morphogenetic proteins

Regulation of osteoclast differentiation

Osteoclast differentiation and activation

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.

Factors regulating the growth of metastatic cancer in bone.

P304

160-167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BONE.2008.09.009

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23393311

http://www.w3.org/2001/XMLSchema#string

P698

18929692

http://www.w3.org/2001/XMLSchema#string

P921

P932

2657045

http://www.w3.org/2001/XMLSchema#string